Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Withdrawn 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Somatostatinoma 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Congenital Abnormalities 2Colonic Neoplasms 2Carcinoma, Islet Cell 2Breast Neoplasms 2Waldenstrom Macroglobulinemia 1Vipoma 1Uterine Cervical Dysplasia 1Urologic Neoplasms 1Thrombocythemia, Essential 1Squamous Intraepithelial Lesions 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pituitary Neoplasms 1Pancreatic Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Melanoma 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1

Interventions

Cytarabine 29Busulfan 12Filgrastim 10Daunorubicin 10Peripheral Blood Stem Cell Transplantation 9Idarubicin 9Mitoxantrone 8Methotrexate 8Etoposide 8Cyclosporine 8Gemtuzumab 7Cyclophosphamide 7sargramostim 6fludarabine phosphate 6Azacitidine 6Antilymphocyte Serum 6Decitabine 5tipifarnib 4alvocidib 4Tacrolimus 4Injections 4Cyclosporins 4Biopsy 4Whole-Body Irradiation 3Vorinostat 3Radiotherapy 3Mycophenolic Acid 3Flow Cytometry 3Cytogenetic Analysis 3Clofarabine 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Monocytic, Acute × Biological Therapy × Clear all
NCT00101140 2017-10-19

Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia in Remission

Eastern Cooperative Oncology Group

Phase 2 Withdrawn
Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡